Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway - Top-Institutions - MDSpire

Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway

  • By

  • Sophie Scholz

  • Julia Prinz

  • Linde Sevenants

  • Andrea Holzwarth

  • Birgit Mertens

  • Robert Pieper

  • Vera Ritz

  • Kirsten Schulz

  • Holger Sieg

  • Aswin Mangerich

  • Linda Böhmert

  • June 27, 2026

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    European Commission — Joint Research Centre
    European Commission — Joint Research Centre

    Ispra, Varese

    Key Differentiators

    • Nanotechnology
    • Regulatory Science

  • #2

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Environmental Medicine
    • Toxicology

  • #3

    State University of Campinas
    State University of Campinas

    São Paulo, Brazil

    Key Differentiators

    • Cell Biology
    • Toxicology

  • #4

    Federal Technological University of Paraná
    Federal Technological University of Paraná

    Londrina, Brazil

    Key Differentiators

    • Nanotechnology
    • Pharmaceutical Sciences

Original Source(s)

Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway

  • by Sophie Scholz, Julia Prinz, Linde Sevenants, Andrea Holzwarth, Birgit Mertens, Robert Pieper, Vera Ritz, Kirsten Schulz, Holger Sieg, Aswin Mangerich, Linda Böhmert

  • June 27, 2026

Related Content

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis

Mass Spec Roundup: Hidden Signals and Sharper Reads

From hidden brain lipids to small-volume gas samples, mass spectrometry separates what overlap, scarcity, and similarity can obscure 

  • June 24, 2026

  • 6 min
Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report